Phase 1 Study of CM082 in Patients With wAMD

Clinical trial NCT02452385 · SUSPENDED

Trial details

NCT number: NCT02452385
Sponsor: AnewPharma
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2015-03-01
Primary completion: 2020-06-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.